Councils - Pulmonary Transplantation


SCIENTIFIC COUNCIL ON PULMONARY TRANSPLANTATION
QUICK LINKS

●  Dec 2011 Teleconference Minutes PDF
●  2011 Council Meeting Minutes PDF
●  2011 Council Report to Board PowerPoint
●  2011 Council Meeting Agenda PDF
●  March 14, 2011 Teleconference Call Minutes  PDF
●  DCD Guidelines PDF
Join in the Discussion!

All ISHLT members with an interest in lung transplantation are invited to join the ISHLT Lung Transplant Discussion Group. Subscribers will be able to tap into a worldwide community of lung transplant professionals. This group will cover everything lung transplant, and only members will be able to post and view group content, including members list. To receive an invitation to join, please send an introductory email to our discussion group moderator, Remzi Bag, at remzi.bag@emory.edu - from your professional email address with credentials (name, professional title, affiliation and full contact information).  Sorry, this group is not open to industry.
COUNCIL CHAIRS
Lianne G. Singer, MD, FRCPC
CHAIR
Toronto General Hospital
Toronto, Ontario, CANADA
416-340-4996
lianne.singer@uhn.on.ca
Lianne Singer, MD, FRCPC is Medical Director of the Toronto Lung Transplant Program and Clinical Trials Director, Multi-Organ Transplant Program, at the University Health Network in Toronto, Ontario, Canada. She is also Assistant Professor in the Department of Medicine at the University of Toronto. She completed medical school, Internal Medicine and Respirology training at the University of Toronto. She went on to do a Lung and Heart-Lung Transplantation Fellowship at Stanford University, and advanced training in clinical research at the University of California, San Francisco.

Dr. Singer's research interests arise directly from her clinical focus in lung transplantation. Research subjects include health-related quality of life assessment in advanced lung disease and lung transplantation, decision analysis modeling of lung transplant outcomes to inform clinical decision making and organ allocation policy, and the impact of post-transplant weight gain on clinical and functional outcomes.
david weillDavid Weill, MD
VICE CHAIR
Stanford University Medical Center
Stanford, California, USA
650-724-6795
dweill@stanford.edu
David Weill, MD, is Director of the Center for Advanced Lung Disease, the Adult Cystic Fibrosis Center and Medical Director of the Lung and Heart-Lung Transplant Program at Stanford University Hospitals and Clinics in Stanford, California.

Dr. Weill received his medical degree from Tulane University School of Medicine, completed his residency at the University of Texas Southwestern Medical Center, and a fellowship at the University of Colorado School of Medicine. He is board certified in Pulmonary Disease and Creitical Care from the American Board of Internal Medicine.
Michael Mulligan, MD
VICE CHAIR-ELECT / SECRETARY
University of Washington School of Medicine
Seattle, Washington, USA
206-543-3093
msmmd@u.washington.edu
Dr. Michael S. Mulligan is an Endowed Professor in Lung Transplant Research, Chief of the Thoracic Surgery Section, Director of the Lung Transplant Program and Minimally Invasive Surgery Program as well as Director of the Cardiothoracic Research Laboratory at the University of Washington, Seattle, Washington, and one of the only surgeons in the Pacific Northwest who performs pulmonary endarterectomies for chronic pulmonary embolic disease. He organizes national courses in VATS lobectomy and critical care, and lectures internationally on lung transplantation and lung donor management. His laboratory has been consistently funded by the NIH and investigates mechanisms involved in acute lung transplant dysfunction. Dr. Mulligan attended medical school at the University of Connecticut. He completed his general surgery residency at Columbia Presbyterian in Noew York, NY and took time out during his residency for a two-year post doctoral research fellowship in the laboratory of Dr. Peter Ward at the University of Michigan in Ann Arbor, Michigan. He subsequently completed a heart and lung transplant fellowship at the University of Michigan, followed by a cardiothoracic residency at the University of Michigan and finally a general thoracic fellowship, also at the University of Michigan. During that final year in Ann Arbor, he traveled to San Diego to further study the diagnosis and treatment of Chronic Thromboembolic Hypertension.
Geert M. Verleden, MD, PhD
PAST CHAIR
University Hosptial Gasthuisberg
Leuven, BELGIUM
32-16-34-68-09
geert.verleden@uzleuven.be
G.M. Verleden obtained his MD degree in 1983 and his PhD in 1993, after being trained in internal medicine, pulmonary medicine and intensive care medicine. He is currently full professor of Pulmonary Medicine at the Katholieke Universiteit Leuven and at the University Hospital Gasthuisberg in Belgium. He is the medical director of the Leuven Lung Transplant programme, which was initiated in 1991. His research interests are primarily in the area of inflammation of the airways with particular interest in the role of the airway smooth muscle and the neutrophils in chronic rejection after lung transplantation and the potential role of neo-macrolides to treat this condition.
ISHLT BOARD OF DIRECTORS LIAISON
Duane Davis, MD
ISHLT SECRETARY TREASURER
Duke University Medical Center
Durham, North Carolina, USA
919-681-4760
davis053@mc.duke.edu
Dr. Duane Davis is the Director of Transplantation at the Duke University Medical Center and is Professor of Surgery at the Duke University School of Medicine. He also is the Surgical Director of Thoracic Transplantation - one of the largest heart and lung transplant programs in the world. Dr. Davis received his MD from the UCLA School of Medicine. He completed his general and cardiac surgery residencies at Duke University and additional training in lung transplantation at Barnes-Jewish/ Washington University. He received additional training and mentoring in transplant immunology research under Jeffrey Platt. He has an active role as a physician-scientist and a leadership role at Duke University.
2012 PROGRAM COMMITTEE REPRESENTATIVES
Deborah J. Levine, MD
UT Health Science Center
San Antonio, Texas, USA
210-567-5616
levinedj@uthscsa.edu
Bio coming soon...
Mark L. Barr, MD
University of Southern California
Los Angeles, California, USA
323-442-5849
mbarr@surgery.usc.edu
Mark L. Barr, MD, is Associate Professor of Cardiothoracic Surgery (with tenure) at the University of Southern California Keck School of Medicine where he is Co-Director of Cardiothoracic Transplantation and Associate Director of Cardiothoracic Surgical Research. He obtained his medical degree from Mount Sinai School of Medicine in New York and completed 10 years of postgraduate residency at New York University and Columbia University, including a 2-year NIH-sponsored research fellowship in transplantation immunology.
Glen P. Westall, FRACP, PhD
Alfred Hospital
Melbourne, Victoria, AUSTRALIA
61-3-9276-3600
g.westall@alfred.org.au
Bio coming soon...
Stephen C. Clark, MD
Freeman Hospital
Newcastle Upon Tyne, UK
44-191-233-6161
s.c.clark@ncl.ac.uk
Bio coming soon...
Lorriana Leard
UCSF
San Francisco, California, USA
415-476-8287
lorriana.leard@ucsf.edu
Lorriana Leard, MD, is the Vice Chief of Clinical Activities in the Division of Pulmonary, Critical Care, Allergy and Sleep Medicine, Associate Director of the Pulmonary Critical Care Medicine Fellowship, and Site Director at Moffitt-Long Hospital Internal Medicine Residency Program at the University of California San Francisco.

Dr. Leard received her MD from the University of California San Diego. After completing her Internal Medicine residency at the University of Texas Southwestern in Dallas, she completed her Pulmonary and Critical Care Fellowship at UCSF. She completed an additional subspecialty fellowship in Lung Transplantation at UCSF and joined the faculty in 2006.

Her major academic interests include lung transplantation, interventional bronchoscopy, and lung cancer.
WORKFORCE LEADERS
david weillDavid Weill, MD
STANDARDS AND GUIDELINES WORKFORCE
Stanford University Medical Center
Stanford, California, USA
650-724-6795
dweill@stanford.edu

Workforce Members: PDF
David Weill, MD, is Director of the Center for Advanced Lung Disease, the Adult Cystic Fibrosis Center and Medical Director of the Lung and Heart-Lung Transplant Program at Stanford University Hospitals and Clinics in Stanford, California.

Dr. Weill received his medical degree from Tulane University School of Medicine, completed his residency at the University of Texas Southwestern Medical Center, and a fellowship at the University of Colorado School of Medicine. He is board certified in Pulmonary Disease and Creitical Care from the American Board of Internal Medicine.
Christopher H. Wigfield, MD, FRCS
EDUCATION WORKFORCE
Loyola University Medical Center
Maywood, Illinois, USA
708-327-2488
cwigfield@lumc.edu

Workforce Members: PDF
Christopher Wigfield, MD, FRCS, is Assistant Professor of Thoracic and Cardiovascular Surgery at Loyola University Medical Center in Maywood, Illinois. Dr. Wigfield received his medical schooling at Freie Universitaet Berlin, Germany and the University of Newcastle upon Tyne, United Kingdom. He went on to complete residencies in General Surgery at Royal Berkshire Hospital, UK, Emergency Care at Newcastle upon Tyne Hospitals, UK, General and Vascular Surgery at Freeman Hospital, UK and Cardiothoracic Surgery at Freeman Hospital, UK. He also completed fellowships in Cardiopulmonary Transplantation and Pediatric Cardiac Surgery at Freeman Hospital Cardiothoracic Centre, UK, Cardiothoracic Surgery at Northern Deanery Cardiothoracic Rotation, UK, and Cardiothoracic Surgery at the University of Wisconsin Hospitals and Clinics in Madison, Wisconsin. Dr. Wigfield's special interests are in adult cardiac surgery, chest wall tumors and defects, coronary artery bypass without use of the heart-lung machine, emphysema surgery, heart bypass, heart surgery, laser surgery, lung cancer, lung surgery, lung transplant, minimally invasive surgery, minimally invasive thoracic surgery, pleural effusion, robotic surgery, thoracic surgery, and valve replacement.
Shaf Keshavjee, MD
REGISTRIES AND DATABASES WORKFORCE
Toronto General Hospital
Toronto, Ontario, CANADA
416-340-4010
Dr.Shaf.Keshavjee@uhn.on.ca

Workforce MembersPDF
Dr. Shaf Keshavjee is the Surgeon-in-Chief at University Health Network and the Director of the Toronto Lung Transplant Program, a university program spanning UHN and the Hospital for Sick Children. He is a Professor in the Division of Thoracic Surgery at the University of Toronto. He is also Head of the Joint Division of Thoracic Surgery of UHN and St Joseph’s Hospital, McMaster University.

Dr. Keshavjee completed his medical training at the University of Toronto in 1985. He subsequently trained in General Surgery, Cardiac Surgery and Thoracic Surgery at the University of Toronto followed by fellowship training at Harvard University and the University of London for airway surgery and heart-lung transplantation respectively.

In addition to his clinical practice in Thoracic Surgery at Toronto General Hospital, Dr. Keshavjee leads a team of researchers in a well-established CIHR funded research program and is widely published in the field. His specific research interest is in lung injury related to transplantation. His current work involves the study of molecular diagnostics and gene therapeutic strategies to engineer better organs for lung transplantation.
Roger D. Yusen, MD, MPH
QUALITY OF LIFE WORKFORCE
Washington University School of Medicine
St. Louis, Missouri, USA
314-454-8764
ryusen@dom.wustl.edu

Workforce Members: PDF
Roger Yusen, MD, MPH, is an Associate Professor of Medicine in the Pulmonary and Critical Care Medicine Division of Washington University School of Medicine in St. Louis, Missouri.  Following his medical training at St. Louis University School of Public Health in St. Louis, Missouri, Dr. Yusen completed his residency at Duke University Medical Center in Durham, North Carolina, and a fellowship at the Washington University School of Medicine in St. Louis. His research team focuses its efforts on technology assessment in pulmonary medicine, studying the characteristics and outcomes of patients with end-stage lung disease, especially those with chronic obstructive pulmonary disease (COPD) and emphysema.
Image coming soon...Patrick Evrard, MD
DEVELOPMENT LIAISON
University Hospital of Mont-Godinne
Yvoir, BELGIUM
32-81-42-38-72
patrick.evrard@uclouvain.be
Bio coming soon...
Text SizeIncrease Font SizeDecrease Font Size